According to Future Market Insights’ latest market study, the global loversol market is projected to reach a value of US$ 467.5 million in 2022, with a forecasted compound annual growth rate (CAGR) of 7.0% anticipated between 2022 and 2032. This robust growth indicates a promising trajectory for the Ioversol market over the next decade, driven by increasing demand and advancements in the healthcare and diagnostic industries.
Ioversol is a high-value contrast agent used in medical imaging, primarily in radiology and diagnostic procedures. It belongs to a class of compounds known as non-ionic iodinated contrast media, which are essential tools in modern healthcare for enhancing the visibility of blood vessels and organs during various imaging procedures.
The global ioversol market has experienced steady growth over the years due to the increasing demand for diagnostic imaging services and the rising prevalence of various medical conditions that require accurate diagnosis and monitoring.
Elevate Your Market Presence and Request a Sample Report to Gain Advantage! https://www.futuremarketinsights.com/reports/sample/rep-gb-2287
Key Market Drivers:
- Growing Diagnostic Imaging Procedures: The Ioversol market has witnessed consistent growth due to the increasing number of diagnostic imaging procedures. These procedures are crucial for early disease detection and monitoring, which is essential for improving patient outcomes. As healthcare providers adopt advanced imaging technologies, the demand for contrast agents like ioversol continues to rise.
- Rising Incidence of Chronic Diseases: Chronic diseases such as heart disease, cancer, and kidney disorders are on the rise globally. These conditions often require frequent imaging for diagnosis and treatment planning. Ioversol is frequently used in cardiac angiography, CT scans, and other imaging procedures to provide clear and accurate results, driving its demand.
- Advancements in Healthcare Infrastructure: The continuous improvement in healthcare infrastructure and access to medical services in emerging economies is bolstering the ioversol market. As more hospitals and clinics invest in state-of-the-art imaging equipment, the need for contrast agents like ioversol increases.
Key Companies Profiled in the Ioversol Market
- Liebel-Flarsheim Company LLC
- Guerbet
- Jiangsu Hengrui Medicine Co.
- Mallinckrodt Pharmaceuticals
- Ultraject
- China Resources Pharmaceutical Co.
- HB Ocean
- Changzhou Highassay Chemical Co., Ltd.
- Novalek Pharmaceuticals Pvt. Ltd
- Stellence Pharmscience Pvt. Ltd.
- A.S. Joshi & Company
Ready to scale your business? Start by obtaining the essential insights you need with a custom report crafted exclusively for you. Request it now! https://www.futuremarketinsights.com/customization-available/rep-gb-2287
Ioversol Market Segmentation
By Type
- Ioversol 34% Injectable Solution (Optiray 160)
- Ioversol 51% Injectable Solution (Optiray 240)
- Ioversol 64% Injectable Solution (Optiray 300)
- Ioversol 68% Injectable Solution (Optiray 320)
- Ioversol 74% Injectable Solution (Optiray 350)
By Packaging
- Vials
- Bottles
- Hand-Held Syringes
- Power Injector Syringes
By Application
- X-ray
- CT scan
- Radiological & Diagnostic Examinations
- Angiography
- Urography
- Computed Tomographic Scans
- Others.
By Region
- North America
- Latin America
- Europe
- South Asia Pacific
- East Asia
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube